Can-Fite BioPharma's American depositary shares slid after its board of directors approved a 1-for-3,000 reverse share split.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback